Literature DB >> 22235788

Investigation of power and frequency for 3D conformal MRI-controlled transurethral ultrasound therapy with a dual frequency multi-element transducer.

William Apoutou N'djin1, Mathieu Burtnyk, Michael Bronskill, Rajiv Chopra.   

Abstract

Transurethral ultrasound therapy uses real-time magnetic resonance (MR) temperature feedback to enable the 3D control of thermal therapy accurately in a region within the prostate. Previous canine studies showed the feasibility of this method in vivo. The aim of this study was to reduce the procedure time, while maintaining targeting accuracy, by investigating new combinations of treatment parameters. Simulations and validation experiments in gel phantoms were used, with a collection of nine 3D realistic target prostate boundaries obtained from previous preclinical studies, where multi-slice MR images were acquired with the transurethral device in place. Acoustic power and rotation rate were varied based on temperature feedback at the prostate boundary. Maximum acoustic power and rotation rate were optimised interdependently, as a function of prostate radius and transducer operating frequency. The concept of dual frequency transducers was studied, using the fundamental frequency or the third harmonic component depending on the prostate radius. Numerical modelling enabled assessment of the effects of several acoustic parameters on treatment outcomes. The range of treatable prostate radii extended with increasing power, and tended to narrow with decreasing frequency. Reducing the frequency from 8 MHz to 4 MHz or increasing the surface acoustic power from 10 to 20 W/cm(2) led to treatment times shorter by up to 50% under appropriate conditions. A dual frequency configuration of 4/12 MHz with 20 W/cm(2) ultrasound intensity exposure can treat entire prostates up to 40 cm(3) in volume within 30 min. The interdependence between power and frequency may, however, require integrating multi-parametric functions in the controller for future optimisations.

Entities:  

Mesh:

Year:  2012        PMID: 22235788     DOI: 10.3109/02656736.2011.622343

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  5 in total

1.  Coagulation of human prostate volumes with MRI-controlled transurethral ultrasound therapy: results in gel phantoms.

Authors:  William Apoutou N'djin; Mathieu Burtnyk; Ilya Kobelevskiy; Stefan Hadjis; Michael Bronskill; Rajiv Chopra
Journal:  Med Phys       Date:  2012-07       Impact factor: 4.071

Review 2.  Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy.

Authors:  Kullervo Hynynen; Ryan M Jones
Journal:  Phys Med Biol       Date:  2016-08-05       Impact factor: 3.609

Review 3.  Catheter-based ultrasound technology for image-guided thermal therapy: current technology and applications.

Authors:  Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2015-03-23       Impact factor: 3.914

4.  Development of robust/predictive control strategies for image-guided ablative treatments using a minimally invasive ultrasound applicator.

Authors:  Amin Yazdanpanah Goharrizi; Raymond Kwong; Rajiv Chopra
Journal:  Int J Hyperthermia       Date:  2014-10-14       Impact factor: 3.914

Review 5.  Modelling of endoluminal and interstitial ultrasound hyperthermia and thermal ablation: applications for device design, feedback control and treatment planning.

Authors:  Punit Prakash; Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2013-06       Impact factor: 3.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.